Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

18.89 -0.89 (-4.52%)

Streaming Delayed Price Updated: 3:55 PM EDT, Jul 22, 2026 Add to My Watchlist

Price and Volume

Volume	1,248,374
Open	19.72
Bid (Size)	18.88 (600)
Ask (Size)	18.91 (600)
Prev. Close	19.79
Today's Range	18.77 - 19.92
52wk Range	4.300 - 40.37
Shares Outstanding	45,711,975
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Curious about the stocks that are showing activity after the closing bell on Monday? ↗

July 13, 2026

Via Chartmill

Capricor Therapeutics Eyes FDA Approval Path for Duchenne Cell Therapy ↗

June 11, 2026

Capricor Therapeutics (NASDAQ:CAPR) executives said the company is in active discussions with the U.S. Food and Drug Administration as it works toward a potential approval decision for deramiocel, its...

Via MarketBeat

Performance

YTD	-33.3%	-33.3%
1 Month	-35.6%	-35.6%
3 Month	-46.5%	-46.5%
6 Month	-21.9%	-21.9%
1 Year	+201.4%	+201.4%

More News

Capricor (CAPR) Q1 2026 Earnings Transcript ↗

May 14, 2026

Via The Motley Fool

Capricor Therapeutics Inc (NASDAQ:CAPR) Q1 Results Show EPS Miss as Market Awaits August PDUFA Date ↗

May 12, 2026

Via Chartmill

Capricor Therapeutics Inc (NASDAQ:CAPR) Reports Q4 2025 Loss, Focus Remains on FDA Review for Deramiocel ↗

March 12, 2026

Via Chartmill

Capricor Therapeutics Q1 Earnings Call Highlights ↗

May 12, 2026

Via MarketBeat

Capricor's Insider Just Sold Big — Her Options Tell the rest of the Story ↗

May 10, 2026

Via The Motley Fool

CAPR Stock Slumps But Wall Street Reiterates Optimism For Deramiocel Approval ↗

March 13, 2026

Via Stocktwits

CAPR Stock Heads For Best Week In Nearly A Month: CEO Says 'No Way' Deramiocel Gets Only Conditional Approval ↗

March 13, 2026

Via Stocktwits

Capricor (CAPR) Q4 2025 Earnings Call Transcript ↗

March 12, 2026

Via The Motley Fool

Capricor Reports Wider Quarterly Loss Than Expected But All Eyes Are On Muscle Disease Therapy ↗

March 12, 2026

Via Stocktwits

Capricor Therapeutics’ DMD Treatment Study Shows Improvement In Key Heart Function Measures ↗

March 12, 2026

Via Stocktwits

CAPR Stock Surged 17% Today — What’s Fueling The Rally? ↗

March 10, 2026

Via Stocktwits

CAPR Stock In Spotlight As Investors Eye Next Week’s DMD Trial Data Showing Muscle And Cardiac Gains ↗

March 05, 2026

Via Stocktwits

Capricor Or Sarepta: Two DMD Stocks Enter A High-Stakes Week – Which One Has More Upside? ↗

February 23, 2026

Via Stocktwits

Nasdaq, S&P 500 Futures Fall On Tariff, Iran Tensions: Why NVDA, NFLX, HON, IBRX, MLTX Are On Traders' Radar Today ↗

February 23, 2026

Via Stocktwits

CAPR Stock Rallied Nearly 30% So Far This Week — Here’s The February FDA Catalyst Investors Are Betting On ↗

February 20, 2026

Via Stocktwits

CAPR Stock Slides After FDA Requests More Data For Genetic Disorder Therapy — What Does Retail Think? ↗

January 20, 2026

Via Stocktwits

Here's Why This Biotechnology Skyrocketed by 439% in December ↗

January 09, 2026

Via The Motley Fool

On Friday, there are stocks with unusual volume. Let's take a look. ↗

December 05, 2025

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

December 04, 2025

Via Chartmill

Capricor’s Red-Hot Rally Has Wall Street And Retail Hooked — And Fresh DMD Data Could Keep Fueling The Fire ↗

December 04, 2025

Via Stocktwits

Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results

December 03, 2025

Via MarketMinute

‘Pharma Bro’ Martin Shkreli Calls His Capricor Therapeutics Short A 'Bad Call' After DMD Trial Delivers Surprise Win ↗

December 03, 2025

Via Stocktwits

Why Did Capricor Therapeutics Stock Skyrocket Today? ↗

December 03, 2025

Via Stocktwits

Frequently Asked Questions

Is Capricor Therapeutics, Inc. - Common Stock publicly traded?

Yes, Capricor Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Capricor Therapeutics, Inc. - Common Stock trade on?

Capricor Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Capricor Therapeutics, Inc. - Common Stock?

The ticker symbol for Capricor Therapeutics, Inc. - Common Stock is CAPR on the Nasdaq Stock Market

What is the current price of Capricor Therapeutics, Inc. - Common Stock?

The current price of Capricor Therapeutics, Inc. - Common Stock is 18.89

When was Capricor Therapeutics, Inc. - Common Stock last traded?

The last trade of Capricor Therapeutics, Inc. - Common Stock was at 07/22/26 03:55 PM ET

What is the market capitalization of Capricor Therapeutics, Inc. - Common Stock?

The market capitalization of Capricor Therapeutics, Inc. - Common Stock is 863.73M

How many shares of Capricor Therapeutics, Inc. - Common Stock are outstanding?

Capricor Therapeutics, Inc. - Common Stock has 864M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.